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Bioassay-guided fractionation of a Satureja parvifolia MeOH extract led to the isolation 
of eriodictyol, luteolin and ursolic and oleanolic acids as its active components against Plas­
modium falciparum KI. This is the first time these compounds are reported as constituents 
of S. parvifolia. Ursolic acid showed an IC50 of 4.9 «g/m I. luteolin 6.4«g/iii I. oleanolic acid 
9.3 /ig/ml and eriodictyol 17.2«g/iii I. Antiplasmodial activity of eriodictyol and luteolin is 
reported here for the first time.
Besides, the four compounds showed activity against P. falciparum 3D7 strain and Trypano­
soma brucei rhodesiense. Eriodictyol showed moderate activity on all the parasites but was 
the most selective compound as a result of its rather low cytotoxicity (IC50 174.2 /ig/ml) on 
the mammalian KB cell line.
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Introduction
Satureja parvifolia (Philippi) Epling (Lamia- 
ceae) grows at the verge of rivers descending from 
the hills in the northwestern provinces of Argen­
tina (Salta, Jujuy, Córdoba, Catamarca, Tucumán) 
and is known with the common name of “mufia- 
mufia”. Its traditional uses are as digestive, emme- 
nagogue, aphrodisiac (Bandoni etal., 1972) and 
against altitude sickness (Orfila, 1972). Previous 
investigations on this plant deal with the chemical 
composition and the antifungal activity of its es­
sential oil (Zygadlo and Grosso, 1995; Muschietti 
el al., 1996; Viturro etal., 2000). The brine shrimp 
cytotoxicity (Mongelli et al., 1996), smooth muscle 
relaxant activity on the Guinea pig corpus caver- 
nosum (Hnatyszyn etal., 2003) and antimicrobial 
activity have been reported for S. parvifolia ex­
tracts (Hernández etal., 2000).
In the course of an ongoing screening of Argen­
tine medicinal plants for antiplasmodial activity, 
MeOH and water extracts of S. parvifolia leaves 
showed significant activity against Plasmodium 
falciparum KI with IC50 of 3 and 8.5 ng/ml, respec­
tively (Debenedetti etal., 2002). Bioassay-guided 
fractionation of the MeOH extract was encour­
aged in the search for the bioactive compounds. 
The ability to inhibit Plasmodium falciparum 3D7, 
a chloroquine sensitive strain, and Trypanosoma 




The aerial parts of S. parvifolia were collected in 
Camino al Infiernillo, km 77, Tucumán Province, 
Argentina, in December 2002. A voucher speci­
men (A. Slanis 551) is kept at Instituto Miguel 
Lillo Herbarium, Tucumán, Argentina.
Extraction and isolation
The active MeOH extract was obtained as re­
ported by Debenedetti etal. (2002) and fraction­
ated by column chromatography (CC) on Se­
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phadex LH20 eluted with MeOH. Seven fractions 
were obtained. Fractions 3 and 4 (F3, F4) proved 
to be the most active ones in the antiplasmodial 
assay. F3 was submitted to CC on Sephadex LH20 
eluted with a solvent gradient from 100% EtOAc 
to 100% MeOH. Eleven fractions were obtained. 
Fractions F5 to F7 were purified by paper chroma­
tography (PC) in 40% AcOH. Two bands were 
eluted. F4 was submitted to CC using the same 
gradient as described for F3. A white amorphous 
powder precipitated from fractions F7 to F8. This 
was analyzed by GC-MS.
GC-MS analysis
GC-MS analysis was performed on a Perkin 
Elmer Clarus 500 GC-FID-MS instrument using 
a DB-5 fused-silica column (60 m x 0.25 mm, film 
thickness 0.25 /rm; J&W Scientific Inc.); injector 
(split) temperature: 300 °C; splitting ratio: 1:60; 
oven temperature: 300 °C (isothermic); He: 1.8 ml/ 
min. Using a vent system (MSVent™) at the end 
of the column the flow was spirited into two de­
tectors: a) FID detector maintained at 310 °C; b) 
MS quadrupolar detector (70 eV). Transfer line 
temperature: 180 °C; source temperature: 150 °C; 
scan range: 40-600 Da.
Antiplasmodial assay
Antiplasmodial assay technique was performed 
as described in a previous paper (Debenedetti 
etal., 2002), measuring the uptake of [3H]-hypo- 
xanthine by P. falciparum. The initial concentra­
tion of the fractions was 8 mg/ml diluted in me­
dium to give a final concentration of 40 /rg/ml. The 
percentage growth inhibition on Plasmodium fal­
ciparum KI at this concentration was measured. 
Pure compounds and chloroquine (standard anti­
plasmodial drug) were dissolved in DMSO to give 
stock solutions of 20 mg/ml and diluted with cul­
ture medium to give final concentrations of 100 to 
0.41 yzg/ml against KI (chloroquine-resistant 
strain), 60 to 0.25 /ig/ml against 3D7 (chloroquine­
sensitive strain) and 30 /ig/ml to 0.2 ng/ml for chlo­
roquine against both strains of P. falciparum. 
Threefold serial dilutions of the test compounds 
were made and they were performed in triplicate. 
The highest content of DMSO in the assay was 
0.5%. Each experiment was repeated twice. Statis­
tical analysis was done using the non-paired heter- 
oscedastic Student’s test.
Trypanocidal assay
In vitro cultivation of bloodstream trypomasti- 
gote forms of Trypanosoma brucei rhodesiense 
STIB 900 (susceptible to melarsoprol, pentami­
dine and suramin) and determination of the try­
panocidal activity of the test compounds was car­
ried out as described by Asres etal. (2001). Each 
assay was done in triplicate and repeated at least 
once. Test compounds and pentamidine (as a 
standard antitrypanosomal drug) were dissolved in 
DMSO to give stock solutions of 20 mg/ml and di­
luted with culture medium to give final concentra­
tions of 60 to 0.25 zzg/rnl and 1 /ig/ml to 5.6 pg/ml, 
respectively. The highest content of DMSO in the 
assay was 0.3%.
Cytotoxicity assay
The cytotoxic properties of the test compounds 
were determined as described by Asres etal. 
(2001). The mammalian oral epidermoid carci­
noma cell line KB cultivated in vitro in 10% 
HIFCS in RPMI-1640 was used. Test compounds 
and podophyllotoxin (standard cytotoxic drug) 
were dissolved in DMSO to give stock solutions 
of 20 mg/ml and diluted with culture medium to 
give final concentrations of 300 to 0.3 zzg/ml and 
300 to 0.003 pg/ml, respectively. The highest con­
tent of DMSO was 1.5%.
Results and Discussion
The bioassay-guided fractionation of a Satureja 
parvifolia MeOH extract afforded two major ac­
tive fractions (F3 and F4) which showed inhibition 
of Plasmodium falciparum KI growth (Table I). 
Phytochemical examination of these two fractions 
resulted in the isolation of two flavonoid and two 
triterpenoid compounds.
Table I. P. falciparum KI inhibition by fractions from 
Satureja parvifolia MeOH extract.








0.5% DMSO control 0
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Luteolin and eriodictyol were isolated from F3. 
These compounds were also present in F4. They 
were identified by comparison of their spectro­
scopic data with literature values (Mabry etal., 
1970; Gujer etal., 1986) and by co-chromatogra- 
phy with authentic samples. Ursolic and oleanolic 
acids were identified from F4 by GC-MS analysis. 
The retention times and mass spectra of their 
methyl derivatives were compared with those ob­
tained with authentic samples. The four of them 
inhibited the growth of P. falciparum KI, a chloro­
quine-resistant strain, with IC50 values ranging 
from 4.9 to 17.2 /rg/ml. The isolated compounds 
were further tested for their ability to inhibit the in 
vitro growth of P. falciparum 3D7, a chloroquine­
sensitive strain, and against T. brucei rhodesiense. 
All compounds showed activity against this P. fal­
ciparum strain with IC50 values ranging from 6.3 
to 34.5 ng/ml and against T. brucei rhodesiense (1.5 
to 14.4/ig/ml). Cytotoxicity on mammalian KB 
cell line for these compounds was also assessed 
in order to determine their selectivity against the 
parasites (Tables II and III).
It is worth to point out that eriodictyol show­
ed rather weak cytotoxicity to KB cells (IC50 
174.2 /ig/ml), whilst retaining its antiprotozoal ac­
tivity, it showed a higher selectivity than luteolin 
for the parasite. Luteolin had been previously re­
ported as cytotoxic to other cell lines (Galvez 
et al., 2003).
Trypanocidal activity for eriodictyol on T. brucei 
brucei (Salem and Werbovetz, 2005) and for this 
compound and luteolin on T. cruzi (Grael etal., 
2000, 2005) has already been reported. In our in­
vestigation, trypanocidal activity against T. brucei 
rhodesiense was also found for both compounds 
(IC50 14.4 «g/rnl and 2.3 /rg/ml, respectively) thus 
broadening their antiparasitic activity spectra.
As results of the bioguided fractionation of the 
active extracts of many medicinal plants, ursolic 
and oleanolic acids have been repeatedly reported 
in the literature as the antiparasitic principles 
(Steele et al., 1999; Abe etal., 2002; Suksamrarn 
etal., 2003; Cunha etal., 2003; Taketa etal., 2004). 
The results obtained herein showed activity for 
these two compounds against both P. falciparum 
strains and against T. brucei rhodesiense, consist­
ent with the data found in the literature.
In conclusion, four antiprotozoal compounds: 
ursolic and oleanolic acids, eriodictyol and luteolin 
have been isolated from the Me OH extract of 
S. parvifolia by bioassay-guided fractionation. To 
the best of our knowledge, their presence in this 
species and the antiplasmodial activity of eriodict­
yol and luteolin are reported here for the first 
time. Eriodictyol showed a high selectivity for the 
parasites. This facts makes it an interesting lead 
structure for the development of new antiparasitic 
drugs.
Table II. Antiprotozoal activity and cytotoxicity of ursolic acid, oleanolic acid and eriodictyol from Saturejaparvifolia.
Test compound
IC50 [zig/ml] (average ± std)
P. falciparum KI P. falciparum 3D7 T. brucei Mammalian KB cell line
Ursolic acid 4.9 ± 0.1 12.7 ± 4.6 1.5 ± 0.7 14.1 ± 7.7
Oleanolic acid 9.3 ± 0.2 34.5 ± 1.5 5.1 ± 0.2 77.7 ± 10.7
Eriodictyol 17.2 ± 0.5 27.1 ± 1.7 14.4 ± 1.6 174.2 ± 18.1
Chloroquine 0.17 ± 0.01 0.015 ± 0.005 - -
Pentamidine - - 0.0008 ± 0.0002 -
Podop hyllotoxin - - - 0.001 ± 0.001
Table III. Antiprotozoal activity and cytotoxicity of luteolin from Satureja parvifolia.
Test compound
IC50 [zig/ml] (average ± std)
P. falciparum KI P. falciparum 3D7 T. brucei Mammalian KB cell line
Luteolin 6.4 ± 0.2 6.3 ± 0.8 2.3 ± 1.7 13.3 ± 1.0
Chloroquine 0.09 ± 0.06 0.0075 ± 0.0040 - -
Pentamidine - - 0.0004 ± 0.0001 -
Podop hyllotoxin - - - 0.010 ± 0.001
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